Hydralazine is not a diuretic. It belongs to a completely different drug class called direct-acting vasodilators, and it lowers blood pressure by relaxing the smooth muscle in artery walls rather than by removing excess fluid from the body. The confusion likely arises because hydralazine is frequently prescribed alongside diuretics, and its side-effect profile can actually include fluid retention, which is the opposite of what a diuretic does. Understanding what hydralazine actually does in the body, and why it sometimes needs a diuretic’s help, clears up this common mix-up.
How Hydralazine Relaxes Blood Vessels
Hydralazine works primarily on the arteries and smaller arterioles, the blood vessels that carry oxygen-rich blood away from the heart. Muscle cells wrapped around these vessels control how tightly they squeeze. When those cells contract, the vessel narrows and blood pressure rises. Hydralazine interferes with the calcium signaling those muscle cells rely on to contract. Research on arterial smooth muscle shows that hydralazine disrupts both the flow of calcium into cells from outside and the release of calcium from internal storage compartments within the cell membrane.1Cardiovascular Research. Mechanism of hydralazine-induced relaxation of arterial smooth muscle – Section: SUMMARY A separate study on rabbit aorta tissue found that the drug’s main action is blocking a specific calcium-release pathway inside the cell’s internal calcium stores.2PubMed Central. Inhibition of calcium release from the sarcoplasmic reticulum of rabbit aorta by hydralazine
The net effect is that arterial muscle cells cannot tighten as forcefully, so the vessels widen. This widening reduces what clinicians call systemic vascular resistance, which is essentially the amount of pushback the heart faces when it pumps blood outward. Less resistance means lower blood pressure without the heart needing to pump harder.
The Hemodynamic Picture
Because hydralazine targets arteries rather than veins, its effects on the circulatory system have a distinctive pattern. In a trial comparing hydralazine with isosorbide dinitrate (a venous dilator) in patients with heart failure after a heart attack, hydralazine reduced vascular resistance and raised both cardiac output and stroke volume, while the venous dilator worked through a different mechanism entirely.3Journal of Cardiovascular Pharmacology. Arteriolar or Venous Dilatation in Left Ventricular Failure Following Acute Myocardial Infarction That distinction matters: hydralazine primarily eases the workload on the heart by reducing the resistance it pumps against, rather than reducing the volume of blood returning to it.
In patients who received intravenous hydralazine after cardiac surgery, the drug increased the stroke index by roughly 45% and cut systemic vascular resistance by about 29%, without meaningfully changing other pressures in the system.4PubMed. Specific afterload reduction with parenteral hydralazine following cardiac surgery Similar results have been documented in pregnant women with severe hypertension, where a single intravenous dose dropped mean arterial pressure by about a fifth and slashed vascular resistance by roughly 40%.5PubMed. Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension In both settings, the heart responded to the sudden drop in resistance by increasing its output, a consequence that creates its own set of issues.
Why Hydralazine Can Speed Up Your Heart
One of hydralazine’s best-known side effects is reflex tachycardia, a compensatory rise in heart rate. When arteries suddenly relax and blood pressure falls, the body’s pressure-sensing system detects the dip and triggers the sympathetic nervous system to speed the heart up and try to restore the pressure. Research in healthy volunteers confirmed that this tachycardia is reflex-driven and that its severity varies from person to person depending on how sensitive their individual baroreceptor system is.6PubMed. Hydralazine tachycardia and sympathetic cardiovascular reactivity in normal subjects
Animal studies have added a wrinkle to this picture. In both normal and hypertensive rats, hydralazine appears to trigger two opposing reflexes simultaneously: the arterial baroreflex, which speeds the heart up, and a cardiac mechanoreceptor reflex, which tries to slow it down.7PubMed. Patterns of heart rate responses to hydralazine in normotensive and hypertensive rats In practice, the speeding-up reflex usually wins, which is why hydralazine is so often prescribed alongside a beta-blocker to keep the heart rate from climbing uncomfortably high. This combination is standard clinical practice: the vasodilator lowers resistance while the beta-blocker blunts the reflex acceleration.
Why Hydralazine Gets Confused With Diuretics
The confusion between hydralazine and diuretics probably has two roots. First, hydralazine is very commonly prescribed together with a diuretic, so people see both drugs on the same prescription list and conflate the two. Second, and more counterintuitively, hydralazine can cause the body to retain fluid, which is exactly the problem diuretics are designed to solve.
This fluid retention happens because when arteries widen, pressure inside the tiny capillaries can rise, pushing more fluid out of the bloodstream and into surrounding tissues. The drop in blood pressure also activates the renin-angiotensin-aldosterone system, a hormonal cascade that tells the kidneys to hold onto sodium and water. The result is vasodilatory edema, a type of swelling in the legs and ankles that is dose-dependent and particularly common with direct arteriolar dilators like hydralazine.8PubMed. Vasodilatory edema: a common side effect of antihypertensive therapy Interestingly, while adding a diuretic to the regimen is standard practice and does help manage overall fluid balance, that same research notes that diuretics have limited effect on the edema caused specifically by arteriolar dilation, because the swelling stems from local pressure changes in the capillary bed rather than from total body fluid overload.
So hydralazine does the opposite of what a diuretic does at the kidney level. A diuretic promotes fluid and sodium loss through the urine. Hydralazine, if anything, promotes fluid retention. The two drugs complement each other precisely because they push in opposite directions on the fluid balance issue.
Where Hydralazine Is Still Used
Hydralazine has been on the market since the 1950s and has largely been replaced by newer blood pressure drugs that come with fewer reflexive side effects and a more forgiving dosing profile.9PubMed Central. The change in the pharmacological significance of dihydralazine (Germany) and hydralazine (USA) A Cochrane review characterized it as a drug that has been supplanted by newer agents with better tolerability in most developed health systems, though it remains widely used in developing countries because of its low cost.10Cochrane Database of Systematic Reviews. Hydralazine versus placebo for primary hypertension That said, hydralazine has carved out a few niches where it remains genuinely useful.
Heart Failure With Reduced Ejection Fraction
The most prominent modern use of hydralazine is in combination with isosorbide dinitrate for heart failure. A landmark trial published in the New England Journal of Medicine found that adding this combination to standard heart failure therapy improved survival among Black patients with advanced heart failure.11PubMed. Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure Registry data from a broader clinical population confirmed that the combination reduced illness and death in patients with heart failure and reduced ejection fraction, including patients who could not tolerate ACE inhibitors or angiotensin receptor blockers.12PubMed Central. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction
The logic behind the pairing is elegant. Hydralazine opens arteries (reducing the resistance the failing heart pumps against), while isosorbide dinitrate opens veins (reducing the volume of blood flooding back to an already overloaded heart). Together they unburden the heart from both directions. Beyond the hemodynamic effect, laboratory work suggests that hydralazine also reduces problematic calcium leaks inside heart muscle cells and scavenges harmful reactive oxygen species, potentially improving the actual contractile function of damaged heart tissue.13PubMed Central. Hydralazine and organic nitrates restore impaired excitation-contraction coupling by reducing calcium leak associated with nitroso-redox imbalance
Severe Hypertension in Pregnancy
Hydralazine has a long history of use for blood pressure emergencies during pregnancy, particularly in preeclampsia. Its safety record in pregnancy is well established, and intravenous hydralazine remains a tool in many obstetric units. However, its standing as a first-line choice has eroded. A meta-analysis of trials comparing hydralazine with other options in severe pregnancy hypertension found that hydralazine was associated with more episodes of maternal low blood pressure, more caesarean sections, more placental abruption, and more fetal heart rate abnormalities compared with alternatives like nifedipine and labetalol.14PubMed Central. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis A head-to-head comparison of labetalol and hydralazine in severe pregnancy-induced hypertension found that labetalol lowered blood pressure somewhat more effectively.15PubMed Central. Comparison of Hydralazine and Labetalol to lower severe hypertension in pregnancy That said, a separate randomized trial reported no side effects at all among patients who received hydralazine, while those who received nifedipine experienced tachycardia.16PubMed Central. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia The conflicting data partly reflects differences in dosing, populations, and trial design. The overall picture is that hydralazine works for pregnancy-related hypertensive emergencies but is no longer the default first choice in guidelines that have moved toward labetalol or nifedipine.
Drug-Induced Lupus
Among hydralazine’s more serious long-term risks is a condition called drug-induced lupus, an autoimmune reaction that can develop after months of use. Unlike the naturally occurring form of lupus, drug-induced lupus typically resolves once the offending medication is stopped. Symptoms often include joint pain, fever, skin rashes, and sometimes inflammation around the heart. In one reported case, a patient on hydralazine for about a year and a half developed recurring fluid buildup around the heart, even though standard antibody testing came back negative, illustrating that the condition can present atypically.17PubMed Central. Hydralazine Induced Lupus Syndrome Presenting with Recurrent Pericardial Effusion and a Negative Antinuclear Antibody
Risk factors for developing this reaction include higher daily doses, treatment lasting longer than three months, being a slow acetylator (more on that shortly), being female, carrying certain genetic markers, and having a family history of autoimmune disease.18PubMed Central. Clinical Characteristics of Hydralazine-induced Lupus Researchers have also explored the biological mechanism and identified enhanced formation of neutrophil extracellular traps, structures released by immune cells, as a potential pathway through which hydralazine triggers the autoimmune response.19PubMed Central. Drug-induced lupus erythematosus: an update on drugs and mechanisms The Cochrane review on hydralazine for hypertension also lists this lupus-like syndrome among the drug’s documented adverse effects, alongside reflex tachycardia, hemolytic anemia, vasculitis, and kidney inflammation.20Cochrane Library. Hydralazine versus placebo for primary hypertension
The Acetylator Variable
One of the more interesting aspects of hydralazine’s pharmacology is how dramatically your genetics can affect the drug’s behavior in your body. Hydralazine is broken down by an enzyme called N-acetyltransferase 2 (NAT2), and roughly half the general population carries gene variants that make this enzyme work slowly. These “slow acetylators” end up with higher drug levels in their blood from the same dose compared with “fast acetylators.”21PubMed Central. Genotype-Guided Hydralazine Therapy
This is not just academic. When taken by mouth, hydralazine goes through extensive first-pass metabolism in the liver before reaching the bloodstream. The fraction that actually makes it through is starkly different depending on acetylator status: slow acetylators absorb roughly 30 to 35% of an oral dose, while fast acetylators absorb only about 10 to 16%.22Clinical Pharmacokinetics. Clinical Pharmacokinetics of Hydralazine That means a fast acetylator may need a meaningfully higher dose to achieve the same blood pressure reduction, while a slow acetylator on the same dose faces a greater risk of side effects, including the lupus-like syndrome described above. When hydralazine is given intravenously, this difference largely disappears because the drug bypasses the liver’s first pass.
The practical implication is that two patients on the same hydralazine prescription can have very different experiences, and genetic testing for NAT2 status could theoretically guide dosing, though this is not yet routine in most clinical settings.
How Hydralazine Compares With Actual Diuretics
To put the original question to rest with some clarity, here is where hydralazine and diuretics differ at every level:
- Site of action: Diuretics work on the kidneys, blocking sodium reabsorption at various points along the kidney’s filtering tubes. Hydralazine works on arterial smooth muscle cells, preventing them from contracting.
- Effect on fluid balance: Diuretics increase urine output and reduce total body fluid volume. Hydralazine tends to cause fluid retention by activating hormonal systems that tell the kidneys to hold onto sodium and water.
- Blood pressure mechanism: Diuretics lower blood pressure partly by reducing blood volume and partly through longer-term effects on vessel wall sodium content. Hydralazine lowers blood pressure by widening arteries and reducing the resistance blood encounters as it flows.
- Heart rate effect: Most diuretics have minimal direct effects on heart rate. Hydralazine frequently triggers a reflex increase in heart rate.
- Typical pairing: The two classes are often prescribed together precisely because they counterbalance each other’s weaknesses. The diuretic offsets the fluid retention hydralazine causes, and hydralazine provides a blood-pressure-lowering mechanism the diuretic alone cannot achieve as potently.
If you have been prescribed hydralazine and also take a diuretic like hydrochlorothiazide or furosemide, the combination is intentional. Each drug handles a different part of the blood pressure problem, and neither one can do the other’s job.
The Antioxidant Side of Hydralazine
Beyond its well-known role as a vasodilator, hydralazine has attracted research interest for biochemical effects that go beyond simple blood vessel relaxation. In laboratory studies on heart muscle cells, hydralazine reduced leakage of calcium from internal storage compartments, improved calcium recycling, and scavenged superoxide, a damaging reactive oxygen species.13PubMed Central. Hydralazine and organic nitrates restore impaired excitation-contraction coupling by reducing calcium leak associated with nitroso-redox imbalance These effects are distinct from the drug’s arterial muscle relaxation and may help explain why the hydralazine-isosorbide dinitrate combination seems to benefit failing hearts beyond what pure pressure reduction would predict.
Whether these antioxidant properties have clinical relevance outside heart failure remains an open question. Some researchers have speculated about broader cardioprotective potential, but for now, these findings are confined to the laboratory bench and to the specific heart failure population where the drug combination has been tested in clinical trials. For the typical patient taking hydralazine for blood pressure control, the primary mechanism that matters day to day is still the straightforward one: relaxing arteries so the heart doesn’t have to push as hard.